Vericrest Private Wealth Precision Biosciences Inc Transaction History
Vericrest Private Wealth
- $81.5 Million
- Q2 2022
A detailed history of Vericrest Private Wealth transactions in Precision Biosciences Inc stock. As of the latest transaction made, Vericrest Private Wealth holds 154,694 shares of DTIL stock, worth $843,082. This represents 0.3% of its overall portfolio holdings.
Number of Shares
154,694Holding current value
$843,082% of portfolio
0.3%Shares
1 transactions
Others Institutions Holding DTIL
# of Institutions
7Shares Held
2.56MCall Options Held
0Put Options Held
0-
Oup Management Co., LLC1.12MShares$6.13 Million0.86% of portfolio
-
Chi Advisors LLC New York, NY607KShares$3.31 Million0.1% of portfolio
-
Jacob Asset Management Of New York LLC Hermosa Beach, CA390KShares$2.13 Million0.19% of portfolio
-
Tekla Capital Management LLC225KShares$1.22 Million0.0% of portfolio
-
American Portfolios Advisors Holbrook, NY33.9KShares$184,9130.0% of portfolio
About PRECISION BIOSCIENCES INC
- Ticker DTIL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 110,818,000
- Market Cap $604M
- Description
- Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...